Presented at ESTRO 2025 in Vienna, Austria, a 10-year study involving over 4,000 UK patients confirms that a one-week course ...

Cash and cash equivalents of $89.4 million as of March 31, 2025 Company expects its cash and cash equivalents will continue ...

Dengue fever now threatens half of the world’s population, but small molecule treatments could be an answer to treating the .